In patients, an additional mechanism of BBB disruption may be contributing to the pathogenesis of CM, where the binding of specific variants of PfEMP1 to EPCR in brain capillaries can block the receptor constitutive activation through activated protein C and result in increased thrombin activity, which would favor loss of endothelial barrier function (48). Here, PROCR is linked to cutaneous mastocytosis.